PT  - JOURNAL ARTICLE
AU  - Edelstein, Jasmine N
AU  - Hill, Tyler F
AU  - Leiken, Michael D
AU  - Molloy, Katherine M
AU  - Adekanye, Glory
AU  - Bullock, Caroline
AU  - Lazorchak, Adam S
AU  - Aryee, Ken-Edwin
AU  - Rawlings, David J
AU  - James, Richard G
AU  - Morgan, Richard A
AU  - Arlauckas, Sean P
TI  - 409 Development of<em>
<em>ex vivo</em>
</em> precision gene engineered B cell medicines that produce highly active and sustained levels of transgenic anti-tumor biologics
AID  - 10.1136/jitc-2023-SITC2023.0409
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A458--A458
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A458.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A458.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.